In Vivo Human Single‐Chain Fragment Variable Phage Display‐Assisted Identification of Galectin‐3 as a New Biomarker of Atherosclerosis
Background Atherosclerosis is a complex pathology in which dysfunctional endothelium, activated leucocytes, macrophages, and lipid‐laden foam cells are implicated, and in which plaque disruption is driven by many putative actors. This study aimed to identify accurate targetable biomarkers using new...
Main Authors: | Audrey Hemadou, Alexandre Fontayne, Jeanny Laroche‐Traineau, Florence Ottones, Philippe Mondon, Stéphane Claverol, Éric Ducasse, Stéphane Sanchez, Sarah Mohamad, Cyril Lorenzato, Martine Duonor‐Cerutti, Gisèle Clofent‐Sanchez, Marie‐Josée Jacobin‐Valat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.016287 |
Similar Items
-
Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library
by: Audrey Hemadou, et al.
Published: (2017-12-01) -
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis
by: Samuel Bonnet, et al.
Published: (2021-05-01) -
A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.
by: Amelie Vallet-Courbin, et al.
Published: (2017-01-01) -
In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
by: Tea Glonti, et al.
Published: (2022-07-01) -
Editorial: Phage Biology and Phage Therapy
by: Shuai Le, et al.
Published: (2022-04-01)